Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received CE Mark approval for its Elecsys® Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay to identify ...
QUANZHOU, FUJIAN, CHINA, February 26, 2026 /EINPresswire.com/ — The global market for personal protective equipment (PPE) has experienced unprecedented growth ...
Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results